OpenAlex
PricingAboutJobs
Log inGet started
Work

GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?

HTML

Year: 2022
Type: review
Source: Current Atherosclerosis Reports
DOI: 10.1007/s11883-022-01062-2
Authors: Maurício Reis Pedrosa, Denise Reis Franco, Hannah Waisberg Gieremek, Camila Maia Vidal, Fernanda Bronzeri, Alexia de Cassia Rocha, Luis Gabriel de Carvalho Cara, Sofia Lenzi Fogo, Freddy Goldberg Eliaschewitz
Language: English

Topic: Pharmacology and Obesity Treatment
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, obesity, cardiovascular disease prevention, cardioprotection, liraglutide, semaglutide, tirzepatide, type 2 diabetes, weight loss, insulin resistance, cardiovascular outcome trials, LEADER trial
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4293740201
FWCI: 1.868
Cites: 121
Cited by: 79
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security